SheridanLamMD
Ophthalmology • Lombard, ILCataract Related, Cornea & External Disease, Uveitis
DuPage Ophthalmology
Dr. Lam is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2500 S Highland Ave
Ste 110
Lombard, IL 60148Phone+1 630-495-2220Fax+1 630-495-2279
Education & Training
University of South Florida MorsaniResidency, Ophthalmology, 1986 - 1989
Swedish HospitalInternship, Transitional Year, 1984 - 1985
Northwestern University The Feinberg School of MedicineClass of 1984
Certifications & Licensure
IL State Medical License 1985 - 2026
IA State Medical License 1990 - 1993
FL State Medical License 1986 - 1989- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
- Fellow (FAAO) American Academy of Ophthalmology
Publications & Presentations
PubMed
- One-sided versus 2-sided statistical analysis of the safety and efficacy of intracameral moxifloxacin to prevent post-cataract endophthalmitis.Sheridan Lam
Journal of Cataract and Refractive Surgery. 2019-06-01 - Blinded by Sight.Sheridan Lam
JAMA. 2018-08-21 - Intracameral moxifloxacin injection to prevent endophthalmitis.Sheridan Lam
Journal of Cataract and Refractive Surgery. 2014-03-01
Journal Articles
- Blinded by SightSheridan Lam, MD, JAMA
Press Mentions
Pelzman's Picks: How Safe Is CRISPR?September 4th, 2018
Blinded by SightAugust 21st, 2018
Professional Memberships
- Fellow
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
